⚡ TL;DR:

The ETA ecosystem has quietly rewritten the playbook this cycle, and most searchers haven't noticed yet. We spent three days at SMBash in Irving, Texas — operators with closed deals, lenders who actually fund the space, and the hallway conversations that mattered more than the main stage.

Inside: Jacob Hall's Four Horsemen of ETA in a 2026 rate environment (max-leverage, overpaying in process, hockey-stick models, going alone), Athena Simpson on why the winning LOI lands five days before the losing one, Peter Lehrman on why 65% of quality lower-middle-market deals never hit the broad market — plus the new SBA citizenship and seller-equity-rollover rules, and Jay Paul Henderson's seven levels of AI adoption with the MEDVi case study that stopped the room.

🛡️ Personal guarantee insurance for SBA 7(a) borrowers

All SBA acquisitions borrowers personally guarantee the loan to close their deal, often for $1M+. Ink offers personal guarantee insurance designed to help protect your personal assets. Launching this summer. Book a call to get your PG exposure analysis and learn how pricing works.

Multi-location audiology practice in Bucks County, Pennsylvania, founded in 2001 — 25 years of operation. Two strategically positioned offices serve a large patient base across eastern PA. The primary audiologist (44 years of clinical expertise) has committed to remaining with the business post-transaction. Owner financing is negotiable for a well-qualified buyer; FF&E of $100K included.

Why this deal stands out: Multi-location healthcare practice with 25 years of operating history, a 38% SDE margin, and the primary clinician committed to staying through transition — this is the profile that drove top-3 click engagement in Newsletter 57. Owner financing availability adds structural flexibility, and the multi-location footprint reduces single-site concentration risk.

💡 EBIT Take: Audiology has a structural tailwind most other healthcare verticals don't — the population aging into hearing loss is far larger than the supply of audiologists. Diligence priorities: (1) payer mix and Medicare reimbursement exposure on hearing aid fittings, (2) staff audiologist credentials and which ones are staying, (3) hearing aid manufacturer relationships and rebate structure (this is often where the real margin lives), and (4) the clinical lead's commitment terms — "remaining with the business" should be papered into the LOI as a multi-year employment agreement. The owner-financing offer is leverage on price.

Analyze with AI →

Northeast Wisconsin hardscape and landscape design firm operating since 1995 — 31 years of continuous operation. The broker title indicates the real estate is included in the $575K asking price. Three-employee operation generating $1.1M revenue and $459K SDE on a referral-driven residential and light commercial book. Owner is retiring; FF&E valued at $400K and inventory included.

Why this deal stands out: At a 1.25x SDE multiple with a 5.66x DSCR, the financing math here is extraordinary — buyers using SBA 7(a) at 90% LTV would clear roughly $378K in cash flow after annual debt service. The asking-price-includes-real-estate framing in the broker title plus 31 years of operating history and a retiring seller put this in territory where the price tag may simply reflect a small-broker pricing methodology that hasn't caught up to the cash flow.

💡 EBIT Take: Verify the real estate inclusion explicitly with the broker — the listing summary lists FF&E ($400K) but doesn't separately appraise real estate, so confirm what land or building is actually included before treating that hook as priced in. If the RE is genuinely in the deal at $575K, this becomes the rare situation where the underlying property covers most of the down payment. Diligence priorities: (1) RE appraisal and title review, (2) the 3-employee footprint and crew leader retention, (3) referral pipeline structure (which contractors and design firms drive leads), and (4) winter-season cash flow patterns in NE WI. Best fit: an operator who wants a turnkey landscape platform with real estate as the equity anchor.

Analyze with AI →

SBA-prequalified, 23-year-old New York boutique digital marketing agency founded in 2003. Provides SEO, paid search, online reputation management, social media community engagement, and AI/LLM optimization to a carefully maintained roster of long-term clients. Revenue grew from $906K in 2020 to $1.84M in 2025; SDE grew 43% YoY into 2025. Approximately 80% of revenue is recurring monthly. SDE margins consistently above 50%. Average client tenure: 12.4 years.

Why this deal stands out: 23-year-old boutique agencies with 12.4-year average client tenure, 80% recurring revenue, and 50%+ SDE margins are an unusual combination. SBA Pre-Qualification means a buyer can move with as little as 10% down on a 10-year amortization at competitive SBA rates — the structural unlock that turns a $3.68M ask into roughly $368K of equity. AI/LLM optimization in the service mix points to the agency keeping pace with what mid-market clients are actually buying in 2026.

💡 EBIT Take: The 12.4-year client tenure is the asset to underwrite — and the risk is that those tenures reflect founder-relationship anchoring rather than systems-driven retention. Diligence priorities: (1) net retention by cohort over the last 5 years, (2) which top-10 clients are anchored to specific employees vs. the firm, (3) revenue concentration across the top 5 clients, and (4) verify the AI/LLM optimization service line is real production work and not aspirational packaging. The 60% SDE margin is high enough to absorb meaningful client churn during transition, which is the structural reason this works as an SBA target. Best fit: an operator who has run a marketing P&L before, or a strategic acquirer rolling up vertical agencies.

Analyze with AI →

North Salt Lake-based specialized manufacturer of mission-critical night vision, thermal imaging, and proprietary IR/white-light illumination systems used in surveillance, infrastructure, industrial, and defense applications. Nearly three decades of operation in a high-performance niche where reliability, range, and engineering capability drive purchasing decisions. Furniture/fixtures and inventory included in asking price.

Why this deal stands out: Proprietary IR and thermal imaging systems sold into surveillance, defense, and industrial accounts is exactly the kind of niche where 30 years of engineering reps create a moat that bigger players can't replicate without acquisition. The 31% SDE margin reflects pricing power on engineered-spec products rather than commodity competition. Defense and infrastructure buyers prioritize long-term supply continuity, which favors incumbent suppliers in the bid process.

💡 EBIT Take: Defense and surveillance verticals carry export-control implications that need to be priced into diligence. ITAR or EAR designation on any product line means the buyer must be a U.S. citizen and may require pre-acquisition export-control disclosures. Diligence priorities: (1) ITAR/EAR classification of the product portfolio, (2) customer concentration across defense primes, government agencies, and industrial accounts, (3) IP — patents, registered marks, or trade secrets that protect the proprietary IR designs, and (4) engineering staff retention plan. Best fit: a buyer with mil-spec or industrial sensor backgrounds.

Analyze with AI →

Highly profitable pharmacy in Western Florida combining retail and compounding, filling 32,000 prescriptions per year on $2.9M in annual sales. Net to owner in 2025 after fully staffed operations was $1.13M. Estimated inventory of $90K. Compounding is the niche differentiation — a regulated specialty within retail pharmacy that requires specific licensure and equipment, creating barriers to entry that commodity pharmacies don't have.

Why this deal stands out: $1.13M of net-to-owner cash flow at $3.4M ask is a 3.0x SDE multiple — at the favorable end for licensed healthcare-adjacent operations. Compounding pharmacies operate in a regulated niche where licensure, technicians, and equipment create real switching costs for prescribing physicians. "Fully staffed" is the line that matters here — the SDE was generated with the owner already not running the counter, which is the structural prerequisite for an SBA acquirer.

💡 EBIT Take: Compounding revenue is the moat, but it's also the regulatory exposure — DEA licensing, USP 795/797/800 compliance, and state pharmacy board inspections all need to clear cleanly. Diligence priorities: (1) DEA registration status and any open inspection items, (2) compounding license transferability under FL state rules and 503A vs 503B classification, (3) prescriber relationships — how many physicians drive the top 50% of compounding revenue and how concentrated is that book, and (4) hazardous-drug compounding capability and the capex needed to maintain it. The retail half cushions volatility in any single compounding contract; the compounding half provides the margin. Best fit: a pharmacist-buyer or a healthcare operator partnering with a managing pharmacist.

Analyze with AI →

Disclaimer: This guide is for educational purposes only and does not constitute legal, financial, tax, or investment advice. Business acquisitions involve significant risks, and outcomes can vary widely based on individual circumstances. Always consult with qualified professionals including attorneys, CPAs, and financial advisors before making acquisition decisions. The EBIT Community does not guarantee the accuracy of information provided or the success of any acquisition strategy. Past performance and examples do not guarantee future results.